CYGNAL Trademark

Trademark Overview

On Friday, October 11, 2019, a trademark application was filed for CYGNAL with the United States Patent and Trademark Office. The USPTO has given the CYGNAL trademark a serial number of 88651496. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 27, 2022. This trademark is owned by Cygnal Therapeutics, Inc.. The CYGNAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals
cygnal

General Information

Serial Number88651496
Word MarkCYGNAL
Filing DateFriday, October 11, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 27, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 30, 2021

Trademark Statements

Description of MarkThe mark consists of the word "CYGNAL" in stylized letters.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, January 30, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCygnal Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameCygnal Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, June 27, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 27, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 19, 2021SOU EXTENSION 1 GRANTED
Friday, November 19, 2021SOU EXTENSION 1 FILED
Friday, November 19, 2021TEAS EXTENSION RECEIVED
Tuesday, May 25, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 30, 2021PUBLISHED FOR OPPOSITION
Friday, March 26, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 26, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 29, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, October 20, 2020ASSIGNED TO EXAMINER
Sunday, August 2, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, August 2, 2020FINAL REFUSAL E-MAILED
Sunday, August 2, 2020FINAL REFUSAL WRITTEN
Friday, July 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 9, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 16, 2020NON-FINAL ACTION E-MAILED
Thursday, January 16, 2020NON-FINAL ACTION WRITTEN
Thursday, January 16, 2020ASSIGNED TO EXAMINER
Thursday, October 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

cygnal research development biotechnology pharmaceuticals field scientific biology genomics bioinformatics computational